Poseida Therapeutics: Funding, Investors & Team (Oct 2026)
Poseida Therapeutics is a clinical-stage biopharmaceutical company utilizing genome engineering capabilities to develop targeted therapeutics for patients with high unmet medical needs. The company develops a pipeline of autologous and allogeneic chimeric antigen receptor T cell or CAR-T, product candidates focusing on the treatment of hematological malignancies and solid tumors. Poseida Therapeutics was founded in 2014 and is headquartered in San Diego, California.
Poseida Therapeutics has raised $180M across 2 funding rounds on record, the most recent a Post-IPO Equity of $70.0M announced in Aug 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Poseida Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Poseida Therapeutics Funding Rounds
Poseida Therapeutics raised $110M in an undisclosed round announced in Jun 2020.
2.2 years later, a Post-IPO Equity of $70.0M was announced in Aug 2022.
Poseida Therapeutics Founders and Leadership Team
Contact details for the Poseida Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Poseida Therapeutics Funding Compared to Other Biotechnology Startups
Poseida Therapeutics' latest round of $70.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Poseida Therapeutics in Biotechnology and San Diego
Companies Similar to Poseida Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Poseida Therapeutics Funding FAQs
What does Poseida Therapeutics do?
Poseida Therapeutics is a clinical-stage biopharmaceutical company utilizing genome engineering capabilities to develop targeted therapeutics for patients with high unmet medical needs. The company develops a pipeline of autologous and allogeneic chimeric antigen receptor T cell or CAR-T, product candidates focusing on the treatment of hematological malignancies and solid tumors. Poseida Therapeutics was founded in 2014 and is headquartered in San Diego, California.
How much funding has Poseida Therapeutics raised?
Poseida Therapeutics has raised $180M across 2 rounds on record. The most recent is a Post-IPO Equity of $70.0M announced in Aug 2022.
When did Poseida Therapeutics last raise funding?
Poseida Therapeutics' most recent funding round on record is a Post-IPO Equity of $70.0M, announced in Aug 2022.
Who is the CEO of Poseida Therapeutics?
Eric Ostertag is listed as CEO at Poseida Therapeutics.
Where is Poseida Therapeutics headquartered?
Poseida Therapeutics is based in San Diego, California, United States.
How many employees does Poseida Therapeutics have?
Poseida Therapeutics is in the 251-500 employee band.
How does Poseida Therapeutics' funding compare to other Biotechnology startups?
Poseida Therapeutics' latest round of $70.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Poseida Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Poseida Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.